These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33729690)

  • 1. MicroRNAs and the HIF/VEGF axis in ocular neovascular diseases.
    Plastino F; Pesce NA; André H
    Acta Ophthalmol; 2021 Dec; 99(8):e1255-e1262. PubMed ID: 33729690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
    Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis.
    Mammadzada P; Gudmundsson J; Kvanta A; André H
    Acta Ophthalmol; 2016 Dec; 94(8):805-814. PubMed ID: 27255568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
    Andreoli CM; Miller JW
    Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid Signaling in Ocular Neovascularization.
    Terao R; Kaneko H
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
    Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW
    Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization.
    Liu CH; Sun Y; Li J; Gong Y; Tian KT; Evans LP; Morss PC; Fredrick TW; Saba NJ; Chen J
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12163-8. PubMed ID: 26374840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.
    Vinores SA; Xiao WH; Aslam S; Shen J; Oshima Y; Nambu H; Liu H; Carmeliet P; Campochiaro PA
    J Cell Physiol; 2006 Mar; 206(3):749-58. PubMed ID: 16245301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
    Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
    Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular neovascularization.
    Campochiaro PA
    J Mol Med (Berl); 2013 Mar; 91(3):311-21. PubMed ID: 23329331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vascular endothelial growth factor in ocular angiogenesis.
    Shams N; Ianchulev T
    Ophthalmol Clin North Am; 2006 Sep; 19(3):335-44. PubMed ID: 16935208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of ocular angiogenesis: from development to pathologies.
    Liu CH; Wang Z; Sun Y; Chen J
    FASEB J; 2017 Nov; 31(11):4665-4681. PubMed ID: 28739642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Fairy Chemical Suppresses Retinal Angiogenesis as a HIF Inhibitor.
    Lee D; Miwa Y; Wu J; Shoda C; Jeong H; Kawagishi H; Tsubota K; Kurihara T
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33020402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
    Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
    Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agents that bind annexin A2 suppress ocular neovascularization.
    Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
    J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decorin inhibits angiogenic potential of choroid-retinal endothelial cells by downregulating hypoxia-induced Met, Rac1, HIF-1α and VEGF expression in cocultured retinal pigment epithelial cells.
    Du S; Wang S; Wu Q; Hu J; Li T
    Exp Eye Res; 2013 Nov; 116():151-60. PubMed ID: 24016866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization.
    Kim KL; Seo S; Kim JT; Kim J; Kim W; Yeo Y; Sung JH; Park SG; Suh W
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2120-2131. PubMed ID: 31434494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.